Navigation Links
'Smoke-free' laws lead to fewer hospitalizations and deaths
Date:11/6/2012

Laws that end smoking at work and other public places result in significantly fewer hospitalizations for heart attacks, strokes, asthma and other respiratory conditions, a new UCSF analysis has found.

The research provides evidence that smoke-free laws that cover workplaces, restaurants and bars have the biggest impacts on hospitalizations, reduce health care costs and also raise quality of life, the researchers said.

The research is published in the current issue of the American Heart Association journal Circulation.

"The public, health professionals, and policy makers need to understand that including exemptions and loopholes in legislation such as exempting casinos condemns more people to end up in emergency rooms," said senior author Stanton A. Glantz, PhD, UCSF professor of medicine and director of the Center for Tobacco Control Research and Education at UCSF.

"These unnecessary hospitalizations are the real cost of failing to enact comprehensive smoke-free legislation," he said.

For decades, Glantz and his colleagues at UCSF have been pioneers in tobacco research, disclosing how the tobacco industry manipulated its products and led the public into cigarette addiction.

In the latest study, the scientists examined the relationship between legislated smoking bans and hospital admissions or death from cardiac, cerebrovascular, and respiratory diseases.

The inquiry consisted of a meta-analysis of 45 studies published prior to November 30, 2011. Altogether, the research covered 33 different smoke-free-laws in cities and states around the United States as well as several countries, including New Zealand and Germany. The laws variously prohibit smoking in such public spots as restaurants, bars, and the workplace.

The authors found that comprehensive smoke-free laws were followed rapidly by significantly lower rates of hospital admissions than before the laws went into force:

  • A 15 percent drop in heart attack hospitalizations;
  • A 16 percent drop in stroke hospitalizations;
  • A 24 percent drop in hospitalizations for respiratory diseases including asthma and chronic obstructive pulmonary disease.

Laws that were more comprehensive in scope that included restaurants and bars as well as workplaces -- were followed by larger changes in risk, the authors said. Moreover, the decrease in hospitalizations applied similarly to women and to men, the researchers found.

The authors noted several studies that showed an additional benefit: lower health care costs connected to smoking-related illnesses. The savings reported ranged from $302,000 for acute myocardial infarctions in one small Mississippi town, to $6.9 million the first year after smoke-free laws were implemented in one province in Germany.

"Smoke-free legislationreduces exposure of nonsmokers to secondhand smoke and creates an environment that helps smokers cut down or quit smoking," the authors wrote. "The passage of these laws reflects changes in social norms that also affect smoking behavior; the laws both formalize and accelerate this social change and the associated health benefits."


'/>"/>

Contact: Elizabeth Fernandez
Elizabeth.Fernandez@UCSF.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Related medicine news :

1. Exercise helps smokers to quit smoking, to remain smoke-free and to reduce the risk of death
2. Decline in incidence of heart attacks appears associated with smoke-free workplace laws
3. Higher-spending hospitals have fewer deaths for emergency patients
4. Physician Groups Call for Fewer Medical Tests
5. Pneumococcal disease: More cases but fewer deaths
6. Fewer suicides after antidepressive treatment for schizophrenia
7. Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs
8. Fewer Young Americans Smoking, Survey Finds
9. Fewer Stillbirths Among Pregnant Women Vaccinated Against Flu
10. Nanomedicines promise fewer side effects in treating cancer
11. American Kids Getting Fewer Prescription Drugs: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international ... travel, spa and beauty in Europe. The organization asked its partner experts in Europe ... researchers - to forecast where wellness is headed in Europe. Predictions range from European ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... The Orthopaedic ... executive committee members: , David G. Lewallen, MD, began his term as president ... president. Michael L. Parks, MD, is OREF’s new president-elect. Richard F. Kyle, MD, will ...
(Date:5/31/2016)... , ... May 31, 2016 , ... In a recent ... Feiner and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical ... what she calls the country’s “modern medical money maelstrom.” , During the interview ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet a growing demand ... industry, The University of Scranton is adding a Certificate in Health Informatics to ... in rapidly growing field of healthcare information. , Healthcare organizations are under ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... use inside of FCPX," said Christina Austin - CEO of Pixel Film Studios. ... use within Final Cut Pro X. Choose from abstract transitions to more simple ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
Breaking Medicine Technology: